Latest Bio-Techne News & Updates

See the latest news and media coverage for Bio-Techne. We track all announcements, press releases, and industry mentions in real time, all in one place.

Bio-Techne

Developer and manufacturer of life-science reagents and instruments

bio-techne.com

Headquarters: Minneapolis, United States
Founded year: 1976
Company type: Public company
Number of employees: 2,500–5,000
Industry: Biotechnology & Medical Research

Last updated Today

Latest news about Bio-Techne

In short: Bio-Techne agreed to be acquired by Merck KGaA for $11.3 billion, representing a significant expansion of Merck's life-science business.

Company announcements

June 25 Bio-Techne

Bio-Techne agrees to be acquired by Merck KGaA

The purchase price is $73 per share in cash, with an enterprise value of $11.3 billion, and the deal is expected to close by early 2027.

June 4 Bio-Techne

Bio-Techne and Refeyn launch integrated workflow for bispecific antibody characterization

The workflow combines icIEF fractionation with mass photometry to directly correlate charge and size variants in a four-hour process.

June 3 Bio-Techne

Bio-Techne publishes research on BromoCatch protein-tagging technology

The new self-labelling technology overcomes limitations in tracking smaller and disease-causing proteins for therapeutic research.

May 6 Bio-Techne

Bio-Techne releases Q3 FY2026 results

Revenue declines 2% to $311.4M. GAAP EPS rises to $0.32. Adjusted EPS falls to $0.53. Growth in large pharma and spatial biology.

Media coverage

July 31 GlobalCapital

S&P 500 Futures Climb in Premarket Trading; Bio-Techne, Micron Technology Lead

(TECH) was up 20.9% in pre-market trading, and Micron Technology Inc. (MU) was up 17.7%.

Never miss news about Bio-Techne

Track Bio-Techne and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Bio-Techne competitors & trending companies

Browse news for competitors to Bio-Techne and other trending companies.